MedXCell SA
MedXCell SA is a Swiss biotech venture builder that collaborates with academic institutions to develop early-stage projects in biotechnology, focusing on creating independent ventures targeting major diseases such as cancer and autoimmune disorders.
- Website
- medxcell.ch
- Founded
- 2018
Online destinations
Find MedXCell SA online
Public destinations are grouped by their documented relationship to the organization. A listed link does not by itself prove ownership or control.
Official links
Destinations the organization presents as part of its public presence.
Overview
Founded in 2018, MedXCell SA operates as a venture builder in the biotechnology sector, focusing on transforming scientific breakthroughs into clinical assets. The company collaborates with academic institutions to co-design projects that are commercially viable, targeting significant health challenges including cancer, autoimmune, neurological, and degenerative disorders. MedXCell employs a structured operating model to identify and develop early-stage projects into self-standing ventures, leveraging partnerships with private investors and entrepreneurs.
Check your startup’s fit
Superscout Pro
Build a scout record investors can understand.
- Keep a private deal vault with timestamps
- Write richer memos and evaluations
- Compare investor and program fit
- Manage sources, next actions, and follow-up
Superscout documents MedXCell SA independently from canonical records and linked sources. Missing facts stay missing.
Sources and known limits
A reviewed date is not available for this page.
Terms, dates, and eligibility can change. Confirm time-sensitive details with the original source.
Superscout is not affiliated with, endorsed by, or acting on behalf of the organizations documented here.